⚠️ Disclaimer

Semax is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Semax (Synthetic ACTH(4-10) analog heptapeptide) is researched primarily for BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation. Most extensively clinically used ACTH analog with 40+ years of Russian track record — uniquely bridges neuroprotection (BDNF) with ACTH-independent mechanisms, avoiding the HPA-axis suppression of the parent hormone. It belongs to the Neuropeptide, nootropic, ACTH analog category of compounds.

What Is Semax?

Semax (Synthetic ACTH(4-10) analog heptapeptide) is a Neuropeptide, nootropic, ACTH analog. Developed by Russian scientists in the 1980s as a synthetic ACTH fragment analog for neuroprotection in stroke and cognitive decline.

Most extensively clinically used ACTH analog with 40+ years of Russian track record — uniquely bridges neuroprotection (BDNF) with ACTH-independent mechanisms, avoiding the HPA-axis suppression of the parent hormone. It has attracted significant research interest for its potential effects on BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation.

How Does Semax Produce These Benefits?

Antagonizes α-MSH at MC4/MC5 receptors while inhibiting enkephalin-degrading enzymes to elevate endogenous opioid peptides. Dramatically upregulates BDNF protein for neuronal survival and synaptogenesis. Modulates dopaminergic and serotonergic systems for neuroprotection and cognitive enhancement.

This multi-pathway activity is why Semax shows potential across several different applications rather than being limited to a single use case.

Can Semax Help With Bdnf Elevation?

Research suggests Semax may support BDNF elevation through its neuropeptide, nootropic, acth analog activity. Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Protocols targeting BDNF elevation typically use 200-600 mcg daily administered 2-4 times daily for 5-14 days; repeated cycles with washout.

Can Semax Help With Neuroprotection?

Research suggests Semax may support neuroprotection through its neuropeptide, nootropic, acth analog activity. Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Protocols targeting neuroprotection typically use 200-600 mcg daily administered 2-4 times daily for 5-14 days; repeated cycles with washout.

Can Semax Help With Cognitive Enhancement?

Research suggests Semax may support cognitive enhancement through its neuropeptide, nootropic, acth analog activity. Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Protocols targeting cognitive enhancement typically use 200-600 mcg daily administered 2-4 times daily for 5-14 days; repeated cycles with washout.

Can Semax Help With Stroke Recovery?

Research suggests Semax may support stroke recovery through its neuropeptide, nootropic, acth analog activity. Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Protocols targeting stroke recovery typically use 200-600 mcg daily administered 2-4 times daily for 5-14 days; repeated cycles with washout.

Can Semax Help With Memory Consolidation?

Research suggests Semax may support memory consolidation through its neuropeptide, nootropic, acth analog activity. Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Protocols targeting memory consolidation typically use 200-600 mcg daily administered 2-4 times daily for 5-14 days; repeated cycles with washout.

Can Stacking Enhance Semax Benefits?

Synergizes with Selank — Semax drives BDNF/neuroprotection while Selank provides GABAergic anxiolysis, covering complementary cognitive pathways.

See our Semax stacking guide for detailed combination protocols.

What Is the Bottom Line on Semax Benefits?

Semax is researched for BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation. The evidence base includes: Russian clinical protocols document efficacy for stroke, ischemic injury, and cognitive impairment over 30+ years. Genome-wide transcriptional analysis shows effects on vascular and immune genes. On Russia's List of Vital and Essential Drugs.

Semax is not fda-approved. licensed pharmaceutical in russia. available as research chemical in us. Source from reputable vendors with third-party testing for reliable results.

Complete Guide

Semax: The Russian Nootropic Peptide

Read the Full Guide →

Related Reading

Calculate Your Semax Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Semax.

Open Calculator →

Research-Grade Sourcing

If you're going to research Semax, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Semax

Particle → Browse Semax

Limitless → Browse Semax

Frequently Asked Questions

What is Semax?

Semax (Synthetic ACTH(4-10) analog heptapeptide) is a Neuropeptide, nootropic, ACTH analog. Developed by Russian scientists in the 1980s as a synthetic ACTH fragment analog for neuroprotection in stroke and cognitive decline. It is researched for BDNF elevation, neuroprotection, cognitive enhancement, stroke recovery, memory consolidation.

What is the recommended Semax dosage?

Common dosages: 200-600 mcg daily administered 2-4 times daily via intranasal spray. Cycle length: 5-14 days; repeated cycles with washout. Half-life: not established. Use our peptide calculator for exact reconstitution math.

What are the side effects of Semax?

Nasal irritation (dryness, burning). Nasal cavity discoloration in ~10% of users. Possible increased blood glucose in diabetics. Overall mild adverse effects.

Is Semax safe?

Semax has shown a preliminary safety profile in research. Not FDA-approved. Licensed pharmaceutical in Russia. Available as research chemical in US. All research should follow appropriate safety protocols.